Alkermes Plc (NASDAQ:ALKS)

21.47
Delayed Data
As of Jun 26
 -0.31 / -1.42%
Today’s Change
21.29
Today|||52-Week Range
46.98
-27.25%
Year-to-Date

Today’s Trading

Previous close21.78
Today’s open21.85
Day’s range21.40 - 22.18
Volume888,393
Average volume (3 months)1,144,089
Market cap$3.5B
Data as of 4:00pm ET, 06/26/2019

Growth & Valuation

Earnings growth (last year)+12.81%
Earnings growth (this year)-44.74%
Earnings growth (next 5 years)+36.45%
Revenue growth (last year)+21.13%
P/E ratioNM
Price/Sales4.18
Price/Book3.00

Competitors

 Today’s
change
Today’s
% change
RAREUltragenyx Pharmaceu...+0.25+0.42%
UTHRUnited Therapeutics ...-0.90-1.16%
GBTGlobal Blood Therape...-8.33-13.34%
TAROTaro Pharmaceutical ...-1.01-1.19%
Data as of 4:02pm ET, 06/26/2019

Financials

Next reporting dateJuly 29, 2019
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$1.1B
Annual profit (last year)-$139.3M
Net profit margin-12.73%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Richard F. Pops
Chief Financial Officer &
Senior Vice President
Jim Frates
Corporate headquarters
Dublin, Dublin

Forecasts